MS, L., JC, Z., & R, B. (2025). Sigma receptors and mitochondria-associated ER membranes are converging therapeutic targets for Alzheimer's disease. Frontiers in neuroscience, 19, 1733659. https://doi.org/10.3389/fnins.2025.1733659
Chicago Style (17th ed.) CitationMS, Lotlikar, Zellmer JC, and Bhattacharyya R. "Sigma Receptors and Mitochondria-associated ER Membranes Are Converging Therapeutic Targets for Alzheimer's Disease." Frontiers in Neuroscience 19 (2025): 1733659. https://doi.org/10.3389/fnins.2025.1733659.
MLA (9th ed.) CitationMS, Lotlikar, et al. "Sigma Receptors and Mitochondria-associated ER Membranes Are Converging Therapeutic Targets for Alzheimer's Disease." Frontiers in Neuroscience, vol. 19, 2025, p. 1733659, https://doi.org/10.3389/fnins.2025.1733659.